CD3-directed Antibody Interactions [MoA] - N0000175617

Pharmacologic Class Information

Pharmacologic Code N0000175617
Pharmacologic Name CD3-directed Antibody Interactions
Pharmacologic Uses
  • bispecific CD19-directed CD3 T-cell engager
  • bispecific gp100 peptide-HLA-directed CD3 T cell engager
  • CD3 blocker immunosuppressant (antibody)
  • CD3-directed antibody
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with CD3-directed Antibody Interactions

The table contains 1 products whose active ingredient are classified under the same pharmacologic class CD3-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
80446-401Kimmtrak Non-Proprietary Name: TebentafuspInjection, Solution, ConcentrateIntravenousImmunocore Commercial LlcACTIVE